Evidence against PALB2 involvement in Icelandic breast cancer susceptibility

Several mutations in the PALB2 gene (partner and localizer of BRCA2) have been associated with an increased risk of breast cancer, including a founder mutation, 1592delT, reported in Finnish breast cancer families. Although most often the risk is moderate, it doesn't exclude families with high-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnarsson, Haukur, Arason, Adalgeir, Gillanders, Elizabeth M, Agnarsson, Bjarni A, Johannesdottir, Gudrun, Johannsson, Oskar Th, Barkardottir, Rosa B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491591/
https://www.ncbi.nlm.nih.gov/pubmed/18637200
http://dx.doi.org/10.1186/1477-5751-7-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491591/
https://www.ncbi.nlm.nih.gov/pubmed/18637200
http://dx.doi.org/10.1186/1477-5751-7-5

Ejemplares similares